OEL Fastrac Catalog

Please note, this OEL/ADE monograph also applies to Methenamine hippurate (CAS RN 5714-73-8), Methenamine hydrochloride (CAS RN 24360-05-2/58713-21-6), Methenamine mandelate (CAS RN 587-23-5), Methenamine sulfate (CAS RN 19267-18-6), Methenamine anhydromethylenecitrate (CAS RN 6190-43-8), Methenamine undecylenate (CAS RN 1847-59-2), Hexamethylenetetramine citrate (CAS RN 34317-08-3), Methenamine calcium chloride (CAS RN 20280-08-4), Methenamine diphosphate (CAS RN 72962-49-3), Methenamine benzoate (CAS RN 60168-84-5), Methenamine sulfosalicylate (CAS RN 20480-93-7), Methenamine salicylate (CAS RN 620-34-8), Methenamine sulfosalicylate monohydrate (CAS RN 6033-39-2), Methenamine phosphate (CAS RN 72962-48-2), and Calcium methenamine thiocyanate (CAS RN 859974-17-7). Methenamine is a heterocyclic organic compound with a cage-like structure similar to adamantane. In salt form, it is used for the treatment of urinary tract infections. Methenamine, usually as the hippurate or mandelate, is indicated for the prophylactic or suppressive treatment of frequently recurring urinary tract infections when long-term therapy is considered necessary. This drug is not used to treat infection and should only be used after appropriate eradication of infection with antimicrobial agents.

Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

Why do you need this OEL Fastrac monograph?

OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:

• The numerical OEL and control band assignment needed to determine the level of required engineering controls and personal protective equipment
• A listing of all cited references utilized in the derivation of the OEL and ADE
• An expert review and discussion with respect to the critical endpoints of concern, the rationale for the choice of endpoints, and dose that is to be used in the derivation of the ADE (PDE), as required by the EMA's Guideline on setting health-based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities

Benefits of OEL Fastrac monographs

• Fully documented. Over 20 pages in length, with calculations and cited references.
• Save time! Unsurpassed delivery with instant download.
• Save money. Similar documents cost 5-12 times as much.
• Stay current. Automatic notification of revisions.

How to order

To order an OEL/ADE monograph for Methenamine, just click the ADD TO CART button.

HBEL

If you're wondering about HBEL, we have something for you.